.png?width=200&height=48&name=Tissue-Cypher-White-RGB%20(1).png "Tissue-Cypher-White-RGB (1)"){kind=small}
It's time to think BEyond dysplasia
DDW 2026 is the place to learn about TissueCypher and Barrett’s esophagus risk stratification
If you’re coming to Chicago, book some time with our team to discuss how this innovative test can improve management of patients diagnosed with Barrett’s esophagus. The Castle Biosciences team will be at Booth 4828.
Events featuring TissueCypher
Discordance between clinical and molecular risk stratification in
Barrett's esophagus
Abstract #4486758
The tissue systems pathology test impacts Barrett's surveillance intervals in clinical practice
Abstract #4486677
AI-driven risk prediction tool (TSP-9) informs risk-aligned care for patients with Barrett's esophagus
Sat., May 2, 11:45 a.m. - 12:15 p.m. CT
Mon., May 4, 12:15 - 12:45 p.m. CT
ASGE Learning Center
Presented by
Jay Yepuri, MD
Member of the ACG Board of Trustees
Vice Chairman, GI Alliance Central Division Clinical Governance Board
Member, GI Alliance Physician Executive Board
ASGE Learning Center
Clinical utility scenarios with TissueCypher
Sat., May 2 - Tues., May 5
Come run through Barrett’s esophagus management scenarios with the Castle Biosciences team.
Visit the ASGE Learning Center to participate.
Castle Biosciences will have Area Managers, Medical Science Liaisons, product specialists and others available to answer any question you may have.
Sun., May 3 - Tues., May 5